Therapy Resistance in Prostate Cancer 1st Edition

Capture the cutting edge of cancer research with Therapy Resistance in Prostate Cancer, 1st Edition by Hisham Bahmad. This authoritative volume distills the latest discoveries in molecular mechanisms, tumor microenvironment, and clinical strategies that shape treatment-resistant prostate cancer—an essential read for oncologists, urologists, researchers, and advanced trainees worldwide.

Dive into clear, evidence-based chapters that explain how genetic drivers, adaptive signaling pathways, and immune escape contribute to resistance to hormone therapy, chemotherapy, and targeted agents. Practical clinical insights connect laboratory findings to real-world decision-making for managing castration-resistant prostate cancer (CRPC) and emerging combination therapies. Case-focused discussion and translational perspectives make complex science accessible and actionable for multidisciplinary teams across North America, Europe, and beyond.

Whether you are seeking to sharpen diagnostic acumen, refine treatment planning, or inform research priorities, this book offers a concise roadmap to contemporary challenges and opportunities in prostate cancer care. Expect balanced analysis, clinical relevance, and future-focused commentary on precision medicine, biomarkers, and next-generation therapeutics.

Elevate your practice or research library with a resource that blends rigorous scholarship with pragmatic guidance. Therapy Resistance in Prostate Cancer is a timely reference for anyone committed to improving outcomes for men facing resistant disease.

Order your copy today and stay at the forefront of prostate cancer management—because better understanding leads to better care.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.